Jefferies Downgrades GoodRx Holdings to Hold, Lowers Price Target to $2.75

GoodRx Holdings, Inc. Class A +1.99%

GoodRx Holdings, Inc. Class A

GDRX

2.05

+1.99%

Jefferies analyst Glen Santangelo downgrades GoodRx Holdings (NASDAQ: GDRX) from Buy to Hold and lowers the price target from $5.25 to $2.75.